Finanzwire Finanzwire
Basculer en Français
10349 Companies
215135 Keywords
144978 Articles
113982 Press releases
Headlines Articles Press releases BIOMERIEUX Remove
  1. Home
  2. Companies
  3. BIOMERIEUX
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • REGULATED PRESS RELEASE

    published on 01/08/2024 at 08:22, 2 years 3 months ago

    bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

    bioMérieux has acquired LUMED, a software company specializing in clinical decision support systems to optimize antimicrobial prescriptions and monitor healthcare-associated infections. This acquisition reinforces bioMérieux's commitment to combat antimicrobial resistance and improve infection prevention and control through advanced software solutions.
    BioMérieux LUMED Antimicrobial Resistance Clinical Decision Support System Infection Prevention And Control
    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/26/2023 at 07:01, 2 years 6 months ago

    bioMérieux – Third-Quarter 2023 Business Review

    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/19/2023 at 08:00, 2 years 6 months ago

    bioMérieux makes strategic investment in Oxford Nanopore

    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/13/2023 at 07:02, 2 years 6 months ago

    bioMérieux announces CE-marking of VIDAS® TBI (GFAP, UCH-L1), a test for improved assessment of patients with mild traumatic brain injury, including concussion

    Logo of BIOMERIEUX
Previous page
1 ... 11 12
Accesswire
  • Published on 05/06/2026 at 02:17, 2 hours 9 minutes ago

    Troubadour Announces Share Consolidation and Effective Date

  • Published on 05/06/2026 at 02:00, 2 hours 26 minutes ago

    Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement

  • Published on 05/06/2026 at 02:00, 2 hours 26 minutes ago

    Alset AI Announces Shares for Debt Transaction

  • Published on 05/06/2026 at 01:30, 2 hours 56 minutes ago

    Presentation to RIU Sydney Resources Roundup

  • Published on 05/06/2026 at 01:20, 3 hours 6 minutes ago

    Empress Grants Stock Options and Equity Incentives

View all ACCESSWIRE
EQS Group
  • Published on 05/06/2026 at 03:05, 1 hour 20 minutes ago

    ARC Group Advises Magnax on €35.5 Million Strategic Investment from Pan-International Industrial Corp. and Foxconn Group

  • Published on 05/06/2026 at 03:05, 1 hour 20 minutes ago

    Bank of America Convenes Global Leaders in Asia Pacific for its Breakthrough Technology Dialogue

  • Published on 05/06/2026 at 01:35, 2 hours 50 minutes ago

    VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING

  • Published on 05/06/2026 at 00:05, 4 hours 20 minutes ago

    ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds

  • Published on 05/05/2026 at 23:05, 5 hours 20 minutes ago

    Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1

View all EQS
Les Echos
  • Published on 05/05/2026 at 19:00, 9 hours 26 minutes ago

    Combined General Meeting of Air Liquide Shareholders of May 5, 2026

  • Published on 05/05/2026 at 18:40, 9 hours 46 minutes ago

    Share Buyback program

  • Published on 05/05/2026 at 18:03, 10 hours 22 minutes ago

    Aéroports de Paris SA - Shares and voting rights as of 30 April 2026

  • Published on 05/05/2026 at 17:56, 10 hours 30 minutes ago

    NRJ GROUP - Financial Information Q1 2026

  • Published on 05/05/2026 at 17:53, 10 hours 32 minutes ago

    TF1 - Monthly disclosure of the total number of shares and voting rights - April 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy